Replies to post #56448 on Ayala Pharmaceuticals Inc (ADXS)

[MadCityCyclone]

You'd hope so right? Managing cash/capital/funding is job one for any small biotech. Seems like ADXS has mismanaged it though.

[mortmann]

Interesting. I can't believe this "going concern" issue wasn't in their sights for awhile now... so I'll assume they just misjudged their timing and raised cash at 10 year lows. I would be very perplexed if they announced a non-dilutive deal before the meeting,

Good one. I just burst out laughing when I read that. Add to that the implications of knowing going concern status was questionable and not putting it in the prospectus, BIG SEC NONO. The whole notion that they can raise non dilutive money other ways with 20 mil more cash vs being able with 40 million cash is preposterous. What they're doing is bundling the offering with the proxy to sell it. VOTE NO on additional shares.